SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-10-08 09:20
Tx date 2024-09-30 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights 		$11,749
+19,583 vol
$0.60 each 		71,293
Filed 2023-06-25 23:23
Tx date 2023-06-20 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights 		$11,750
+18,077 vol
$0.65 each 		51,710
Filed 2022-08-21 07:39
Tx date 2022-08-16 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$10,749
+15,638 vol
$0.69 each 		100,000
Filed 2022-08-21 07:36
Tx date 2022-08-16 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal TFSA (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-8,992.98
-14,100 vol
$0.64 each 		0
Filed 2022-08-21 07:33
Tx date 2022-08-16 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$-984.32
-1,538 vol
$0.64 each 		0
Filed 2022-05-19 21:57
Tx date 2022-05-18 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+12,113 vol 		19,793
Filed 2022-05-17 12:52
Tx date 2022-05-13 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights
+16,096 vol 		33,633
Filed 2021-12-28 11:44
Tx date 2021-12-22 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
56 - Grant of rights
+17,537 vol 		17,537
Filed 2021-12-28 11:43
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Units (DSU)
00 - Opening Balance-Initial SEDI Report
Filed 2021-08-26 16:33
Tx date 2021-08-16 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-7,418.0568
-6,153 vol
$1.21 each 		58,500
Filed 2021-08-17 08:33
Tx date 2021-08-17 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-6,153 vol 		26,687
Filed 2021-05-28 16:09
Tx date 2021-05-28 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,700
+6,000 vol
$1.45 each 		62,181
Filed 2021-05-27 10:56
Tx date 2021-05-26 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,771
+1,181 vol
$1.50 each 		56,181
Filed 2021-05-21 12:10
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+7,680 vol 		7,680
Filed 2021-05-20 14:43
Tx date 2021-05-20 		$MRV
Nuvo Pharmaceuticals Inc. (d/b/a Miravo Healthcare) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$16,015
+10,000 vol
$1.60 each 		55,000
Filed 2020-12-23 08:51
Tx date 2020-12-22 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,550
+9,500 vol
$0.90 each 		45,000
Filed 2020-12-23 08:50
Tx date 2020-12-22 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$14,355
+16,500 vol
$0.87 each 		35,500
Filed 2020-12-23 08:45
Tx date 2020-12-22 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,740
+9,000 vol
$0.86 each 		19,000
Filed 2020-12-09 12:55
Tx date 2020-12-04 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,848
+7,596 vol
$0.77 each 		84,362
Filed 2020-12-09 12:55
Tx date 2020-12-04 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,900
+2,500 vol
$0.76 each 		76,766
Filed 2020-11-20 15:28
Tx date 2020-11-20 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-6,626.61
-8,181 vol
$0.81 each 		10,000
Filed 2020-11-20 15:26
Tx date 2020-11-18 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$-19,920
-24,000 vol
$0.83 each 		18,181
Filed 2020-08-21 23:02
Tx date 2020-08-17 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$6,000
+10,000 vol
$0.60 each 		64,653
Filed 2020-05-14 14:09
Tx date 2020-05-13 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+7,000 vol 		32,840
Filed 2020-03-05 15:57
Tx date 2020-03-05 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,448
+2,915 vol
$0.84 each 		42,181
Filed 2019-08-20 09:47
Tx date 2019-08-19 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+7,000 vol 		25,840
Filed 2019-05-25 14:44
Tx date 2019-05-21 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$7,800
+10,000 vol
$0.78 each 		54,653
Filed 2019-05-24 12:00
Tx date 2019-05-21 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$7,800
+10,000 vol
$0.78 each
Filed 2019-05-24 12:00
Tx date 2019-05-21 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$7,800
+10,000 vol
$0.78 each 		54,653
Filed 2019-01-08
Tx date 2019-01-04 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+10,000 vol 		44,653
Filed 2018-05-09
Tx date 2018-05-09 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-2,688 vol 		34,653
Filed 2018-05-07
Tx date 2018-05-06 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-2,688 vol 		18,840
Filed 2018-04-06
Tx date 2018-04-03 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+10,000 vol 		37,341
Filed 2018-03-28
Tx date 2018-03-28 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+7,000 vol 		21,528
Filed 2018-03-16
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
00 - Opening Balance-Initial SEDI Report
Filed 2018-03-16
Tx date 2018-03-13 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
57 - Exercise of rights 		$15,900
+30,000 vol
$0.53 each 		74,266
Filed 2018-03-16
Tx date 2018-03-13 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal (Indirect Ownership)
Common Shares
57 - Exercise of rights 		$407.57
+769 vol
$0.53 each 		1,538
Filed 2018-03-16
Tx date 2018-03-13 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal TFSA (Indirect Ownership)
Common Shares
57 - Exercise of rights 		$3,736
+7,050 vol
$0.53 each 		14,100
Filed 2018-03-16
Tx date 2018-02-16 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
56 - Grant of rights
+75,637 vol 		75,637
Filed 2018-03-16
Tx date 2018-03-13 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Rights Crescita Rights Offering
57 - Exercise of rights 		$-40,087.61
-75,637 vol
$0.53 each 		0
Filed 2017-09-11
Tx date 2017-09-08 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,050
+5,000 vol
$0.61 each 		44,266
Filed 2017-06-28
Tx date 2017-06-28 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+18,500 vol 		27,341
Filed 2017-05-05
Tx date 2017-05-05 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-1,050 vol 		14,528
Filed 2017-05-05
Tx date 2017-05-05 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-1,050 vol 		8,841
Filed 2017-03-08
Tx date 2017-03-07 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+5,687 vol 		15,578
Filed 2016-06-27
Tx date 2016-06-27 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-418 vol 		9,891
Filed 2016-06-27
Tx date 2016-06-27 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options
-418 vol 		9,891
Filed 2016-03-04
Tx date 2016-03-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
38 - Redemption, retraction, cancellation, repurchase
-15,449 vol 		0
Filed 2016-03-04
Tx date 2016-03-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
36 - Conversion or exchange
-34,666 vol 		15,449
Filed 2016-03-04
Tx date 2016-03-01 		$NRI
Nuvo Pharmaceuticals Inc. (formerly, Nuvo Research Inc.) 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
36 - Conversion or exchange
+34,666 vol 		39,266
Filed 2016-03-04
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		10,309
Filed 2016-03-04
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal TFSA (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		7,050
Filed 2016-03-04
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Holder: Spousal (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		769
Filed 2016-03-04
Tx date 2016-03-01 		$CTX
Crescita Therapeutics Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		39,266
Filed 2016-02-29
Tx date 2016-02-29 		$NRI
Nuvo Research Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
97 - Other
-3 vol 		10,309
Filed 2016-02-29
Tx date 2016-02-29 		$NRI
Nuvo Research Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
97 - Other
+5 vol 		50,115
Filed 2016-01-06
Tx date 2016-01-01 		$NRI
Nuvo Research Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+3,810 vol 		50,110
Filed 2016-01-04
Tx date 2015-12-31 		$NRI
Nuvo Research Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+700 vol 		46,300
Filed 2015-10-01
Tx date 2015-10-01 		$NRI
Nuvo Research Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+521 vol 		45,600
Filed 2015-09-24
Tx date 2015-09-21 		$NRI
Nuvo Research Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-9,997
-769 vol
$13.00 each 		10,312
Filed 2015-07-06
Tx date 2015-07-01 		$NRI
Nuvo Research Inc. 		Dobranowski, Anthony Edward
4 - Director of Issuer
Direct Ownership
Deferred Share Unit Plan (DSU)
56 - Grant of rights
+1,026 vol 		45,079